$297.00
Value $78.3B
CignavsEli Lilly and Company
CI and LLY stock compared: price, dividend, valuation and results, from SEC filings.
+0.25%
$1,443.50
Value $1.36T
Cigna (CI) has a market value of $78.3B and Eli Lilly and Company (LLY) $1.36T. Over the last year, with dividends, CI moved +12.2% and LLY +42.9%. The P/E is 13.1 for CI and 49.4 for LLY. Dividend yield: CI 2.08%, LLY 0.44%.
At a glance
The main figures of both. A bar only shows which number is larger, not which is better.
Market value
CI$78.3B
LLY$1.36T
LLY is 17 times CI
Revenue, 12 months
CI$286B
LLY$86.5B
CI is 3.3 times LLY
Net income, 12 months
CI$6.0B
LLY$27.6B
LLY is 4.6 times CI
Operating margin
CI3.4%
LLY–
ROIC
CI10.5%
LLY35.5%
25.0 points apart
P/E
CI13.1
LLY49.4
LLY is 3.8 times CI
Dividend yield
CI2.1%
LLY0.4%
1.7 points apart
5-year return
CI+49.7%
LLY+480.4%
430.7 points apart
A fainter bar means a negative number. The 5-year return includes dividends.
The price over time
Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.
CI+49.7%
LLY+480.5%
| Period | CIWith dividends | LLYWith dividends |
|---|---|---|
| 1 year since November 12, 2025 | +12.2%Price +9.8% | +42.9%Price +41.8% |
| 3 years since November 13, 2023 | +7.0%+2.3% a yearPrice +1.0% | +140.8%+34.0% a yearPrice +135.6% |
| 5 years since November 12, 2021 | +49.7%+8.4% a yearPrice +36.4% | +480.4%+42.2% a yearPrice +455.9% |
| 10 years since November 15, 2016 | +139.8%+9.1% a yearPrice +115.5% | +2,071.6%+36.0% a yearPrice +1,766.9% |
Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.
Every figure
As on each company's page. A description, not a recommendation: no one figure says which is better.
CICignaLLYEli Lilly and Company
Valuation
CILLY| Price | $297.00 | $1,443.50 |
|---|---|---|
| Market value | $78.3B | $1.36T |
| Enterprise value (EV) | $102B | $1.41T |
| P/E | 13.1 | 49.4 |
| P/E, 5-year median | 15.5 | 49.9 |
| P/B | 1.8 | 33.8 |
| EV/EBIT | 10.5 | 40.5 |
| Free cash flow yield | – | 1.4% |
Results and growth
CILLY| Revenue, 12 months | $286B | $86.5B |
|---|---|---|
| Net income, 12 months | $6.0B | $27.6B |
| Free cash flow, 12 months | – | $19.7B |
| Earnings per share, 12 months | $22.68 | $30.81 |
| Revenue growth, year on year | 11.2% | 44.7% |
| Revenue growth a year, past | +11.4%over 5 years | +21.6%over 5 years |
| EPS growth a year, past | -0.7%over 5 years | +27.6%over 5 years |
Margins and returns on capital
CILLY| Gross margin | 20.7% | 83.6% |
|---|---|---|
| Operating margin | 3.4% | – |
| Net margin | 2.1% | 31.9% |
| ROIC | 10.5% | 35.5% |
| ROE | 14.1% | 88.6% |
Balance sheet
CILLY| Cash | $7.3B | $4.9B |
|---|---|---|
| Total debt | $31.1B | $49.5B |
| Net debt / EBITDA | 1.9 | 1.2 |
| Interest cover | 6.9× | 38.9× |
Dividends and buybacks
CILLY| Dividend yield | 2.1% | 0.4% |
|---|---|---|
| Dividend per share, 12 months | $6.19 | $6.34 |
| Dividend growth a year, past | – | +15.2%over 5 years |
| Buyback yield | 4.6% | 0.3% |
| Shareholder yield | 6.7% | 0.7% |
Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.
Which is bigger, Cigna or Eli Lilly and Company?
By market value, Eli Lilly and Company ($1.36T) is about 17.4 times Cigna ($78.3B), at today's prices.
How did CI and LLY stock do over the last 10 years?
Since November 15, 2016, CI's price moved +115.5% and LLY's +1,766.9%. With dividends: CI +139.8% (+9.1% a year), LLY +2,071.6% (+36.0% a year). Past returns do not predict future ones.
Which pays the higher dividend, CI or LLY?
The dividend yield at today's price is 2.08% for Cigna and 0.44% for Eli Lilly and Company. Over the last twelve months they paid $6.19 and $6.34 per share.
What is the P/E of CI and LLY?
At today's price, the P/E is 13.1 for CI and 49.4 for LLY. The median of the last five years was 15.5 and 49.9, which shows where each stands against its own past.
Which has the higher profit margins, Cigna or Eli Lilly and Company?
Over the last twelve months, the net margin was 2.1% for Cigna and 31.9% for Eli Lilly and Company, and the operating margin 3.4% and –. Revenue was $286B and $86.5B.
Which is the better investment, Cigna or Eli Lilly and Company?
The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.
Other comparisons
With each of the two, and with the largest in its sector.
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
US stocksThe market today, the sectors, the largest companies and the week's results.The market's sectorsThe 11 sectors side by side: returns, share of the market, median P/E and dividend.Compare stocksTwo companies side by side: price over up to ten years, with and without dividends, and every figure.US dividend stocksEach dividend's yield next to whether the company's cash covers it and whether it was ever cut.
Descriptive data from SEC filings and market prices.